These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2277810)

  • 1. Actions of the opioid antagonist, nalmefene, and congeners on reperfusion cardiac arrhythmias and regional left coronary blood flow.
    Caldwell RW; Nagarajan R; Chryssanthis A; Tuttle RR
    Pharmacology; 1990; 41(3):161-6. PubMed ID: 2277810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The opiatergic link between the antiarrhythmic effect of adaptation and hypoxia in the model of ischemia and reperfusion in vivo].
    Lishmanov IuB; Naryzhnaia NV; Maslov LN; Gross GJ
    Patol Fiziol Eksp Ter; 2003; (1):19-21. PubMed ID: 12652938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid antagonist modulation of ischaemia-induced ventricular arrhythmias: a peripheral mechanism.
    Murphy DB; Murphy MB
    J Cardiovasc Pharmacol; 1999 Jan; 33(1):122-5. PubMed ID: 9890406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid receptor antagonist nalmefene stereospecifically inhibits glutamate release during global cerebral ischemia.
    Graham SH; Shimizu H; Newman A; Weinstein P; Faden AI
    Brain Res; 1993 Dec; 632(1-2):346-50. PubMed ID: 7908601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kappa-opioid receptor antagonism improves recovery from myocardial stunning in chronically instrumented dogs.
    Grosse Hartlage MA; Theisen MM; Monteiro de Oliveira NP; Van Aken H; Fobker M; Weber TP
    Anesth Analg; 2006 Oct; 103(4):822-32. PubMed ID: 17000788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The opioid receptor antagonist nalmefene reduces responding maintained by ethanol presentation: preclinical studies in ethanol-preferring and outbred Wistar rats.
    June HL; Grey C; Warren-Reese C; Durr LF; Ricks-Cord A; Johnson A; McCane S; Williams LS; Mason D; Cummings R; Lawrence A
    Alcohol Clin Exp Res; 1998 Dec; 22(9):2174-85. PubMed ID: 9884166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the sites of opioid influence on anterior pituitary hormone secretion using a quaternary opiate antagonist.
    Simpkins JW; Swager D; Millard WJ
    Neuroendocrinology; 1991 Oct; 54(4):384-90. PubMed ID: 1661859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral effects of 6-methylene naltrexone (nalmefene) in rhesus monkeys.
    France CP; Gerak LR
    J Pharmacol Exp Ther; 1994 Sep; 270(3):992-9. PubMed ID: 7932212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of delta opioid receptors and their ligands in the development of adaptive heart protection against arrhythmogenesis].
    Naryzhnaia NV; Krylatov AV; Maslov LN; Lishmanov IuB; Gross GJ; Stephano JB
    Ross Fiziol Zh Im I M Sechenova; 2001 Dec; 87(12):1617-25. PubMed ID: 11845802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longer occupancy of opioid receptors by nalmefene compared to naloxone as measured in vivo by a dual-detector system.
    Kim S; Wagner HN; Villemagne VL; Kao PF; Dannals RF; Ravert HT; Joh T; Dixon RB; Civelek AC
    J Nucl Med; 1997 Nov; 38(11):1726-31. PubMed ID: 9374341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of opioid antagonism by nalmefene and naloxone in the dog. A nonparametric pharmacodynamic comparison based on generalized cross-validated spline estimation.
    Wilhelm JA; Veng-Pedersen P; Zakszewski TB; Osifchin E; Waters SJ
    Int J Clin Pharmacol Ther; 1995 Oct; 33(10):540-5. PubMed ID: 8574503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?
    Bart G; Schluger JH; Borg L; Ho A; Bidlack JM; Kreek MJ
    Neuropsychopharmacology; 2005 Dec; 30(12):2254-62. PubMed ID: 15988468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The antiarrhythmic effect of (-)-U-50,488 in rats with acute ischemia and reperfusion of heart is mediated by kappa1-opioid receptor activation].
    Maslov LN; Lishmanov AIu; Solenkova NV; Budankova EV; Wong TM; Chang WC; Bray LX
    Eksp Klin Farmakol; 2005; 68(1):25-9. PubMed ID: 15786960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nalmefene: blockade of intravenous morphine challenge effects in opioid abusing humans.
    Jones HE; Johnson RE; Fudala PJ; Henningfield JE; Heishman SJ
    Drug Alcohol Depend; 2000 Jul; 60(1):29-37. PubMed ID: 10821987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naloxone inhibits arrhythmias induced by coronary artery occlusion and reperfusion in anaesthetized dogs.
    Huang XD; Lee AY; Wong TM; Zhan CY; Zhao YY
    Br J Pharmacol; 1986 Mar; 87(3):475-7. PubMed ID: 3801760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence.
    Walker BM; Koob GF
    Neuropsychopharmacology; 2008 Feb; 33(3):643-52. PubMed ID: 17473837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of kappa-opioid receptors in the regulation of cardiac resistance to arrhythmogenic effects of ischemia and reperfusion].
    Lishmanov AIu; Lasukova TV; Maslov LN; Platonov AA
    Ross Fiziol Zh Im I M Sechenova; 2006 Dec; 92(12):1419-28. PubMed ID: 17523463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of oxygen-derived free radicals in canine reperfusion arrhythmias.
    Euler DE
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H295-300. PubMed ID: 7840275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of L655,240, a selective thromboxane and prostaglandin endoperoxide antagonist, on ischemia- and reperfusion-induced cardiac arrhythmias.
    Wainwright CL; Parratt JR
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):264-71. PubMed ID: 2464097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine effects of naltrexone versus nalmefene in humans.
    Butelman ER; Fry RS; Kimani R; Reed B; Kreek MJ
    Hum Psychopharmacol; 2020 Mar; 35(2):e2726. PubMed ID: 32050055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.